Wednesday, February 8, 2012

Coffee cuts risk of lethal prostate cancer: study

May 26, 2011 by  
Filed under prostate health

Coffee cuts risk of lethal prostate cancer: study WASHINGTON (AFP) – More is better when it comes to drinking coffee to ward off the risk of deadly prostate cancer, according to a major US study released by researchers at the Harvard School of Public Health. Read more on Muzi

Local men lend their faces to the new Prostate Man campaign

May 22, 2011 by  
Filed under prostate health

Local men lend their faces to the new Prostate Man campaign THUNDER BAY, ON – May 16, 2011 – The new faces of the popular Prostate Man campaign were revealed today, and they prove that, indeed, every man can be Prostate Man. Read more on Lake Superior News

Published 15-Year Clinical Review Supports EDAP’s Ablatherm(R) HIFU as Viable Primary Treatment for Local Prostate …

May 16, 2011 by  
Filed under prostate health

Published 15-Year Clinical Review Supports EDAP’s Ablatherm(R) HIFU as Viable Primary Treatment for Local Prostate … LYON, France — EDAP TMS SA , the global leader in therapeutic ultrasound, announced a published 15-year clinical review of Ablatherm HIFU data supports the potential for this minimally invasive treatment to be used as a primary local therapy [...]

Astellas and Medivation Announce Initiation of Phase 2 Clinical Trial of MDV3100 in Hormone-Naive Prostate Cancer …

May 14, 2011 by  
Filed under prostate health

Astellas and Medivation Announce Initiation of Phase 2 Clinical Trial of MDV3100 in Hormone-Naive Prostate Cancer … Second Phase 2 Clinical Trial of MDV3100 in Earlier-Stage Disease Read more on Marketwire

ZYTIGA (abiraterone acetate) Receives FDA Approval for Treatment of Metastatic Prostate Cancer After Priority Review

May 5, 2011 by  
Filed under prostate health

ZYTIGA (abiraterone acetate) Receives FDA Approval for Treatment of Metastatic Prostate Cancer After Priority Review Centocor Ortho Biotech Inc. announced today that the U.S. Food and Drug Administration has approved ZYTIGA⢠, an oral, once-daily medication for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who have received [...]

St. John’s coach Steve Lavin has prostate cancer

April 15, 2011 by  
Filed under prostate health

St. John’s coach Steve Lavin has prostate cancer Steve Lavin, who revived St. John’s basketball in his first season with the Red Storm, has prostate cancer but his doctor expects him to keep coaching and make a complete recovery. The 46-year-old Lavin said in a statement Friday he was diagnosed in September and was told [...]

St. John’s coach Lavin has prostate cancer

April 13, 2011 by  
Filed under prostate health

St. John’s coach Lavin has prostate cancer Steve Lavin, who revived St. John’s basketball in his first season with the Red Storm, has prostate cancer but his doctor expects him to keep coaching and make a complete recovery. Read more on MyCentralJersey.com

Medicare to Cover Pricey Prostate Cancer Drug

April 6, 2011 by  
Filed under prostate health

Medicare to Cover Pricey Prostate Cancer Drug Medicare plans to pay for the pricey prostate cancer immunotherapy Provenge. Read more on ABC News

Toronto hospital speeds up prostate biopsy results for faster treatment

April 5, 2011 by  
Filed under prostate health

Toronto hospital speeds up prostate biopsy results for faster treatment Making the process more efficient also helps improve patients’ anxiety levels, say doctors at Sunnybrook Health Sciences Centre Read more on The Globe and Mail

New tool allows for an alternate method of prostate cancer diagnosis

April 5, 2011 by  
Filed under prostate health

New tool allows for an alternate method of prostate cancer diagnosis ( American Association for Cancer Research ) Researchers have found that it may not be necessary to look for tumors directly in patients with prostate cancer — analyzing non-tumor tissue may be an effective option, according to study results published in Cancer Research, a [...]

Next Page »

Powered by Yahoo! Answers